Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia

Zoe L. Lyski; Myung S. Kim; David Xthona Lee; Hans Peter Raué; Vikram Raghunathan; Janet Griffin; Debbie Ryan; Amanda E. Brunton; Marcel E. Curlin; Mark K. Slifka; William B. Messer; Stephen E. Spurgeon

doi:10.1182/bloodadvances.2021006633

Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia

Zoe L. Lyski, Myung S. Kim, David Xthona Lee, Hans Peter Raué, Vikram Raghunathan, Janet Griffin, Debbie Ryan, Amanda E. Brunton, Marcel E. Curlin, Mark K. Slifka, William B. Messer, Stephen E. Spurgeon

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Original language	English (US)
Pages (from-to)	1207-1211
Number of pages	5
Journal	Blood Advances
Volume	6
Issue number	4
DOIs	https://doi.org/10.1182/bloodadvances.2021006633
State	Published - Feb 22 2022

ASJC Scopus subject areas

Hematology

Access to Document

10.1182/bloodadvances.2021006633

Cite this

Lyski, Z. L., Kim, M. S., Lee, D. X., Raué, H. P., Raghunathan, V., Griffin, J., Ryan, D., Brunton, A. E., Curlin, M. E., Slifka, M. K., Messer, W. B., & Spurgeon, S. E. (2022). Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia. Blood Advances, 6(4), 1207-1211. https://doi.org/10.1182/bloodadvances.2021006633

@article{26d59effe95c4a1bb0b33c1ef7623284,

title = "Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia",

author = "Lyski, {Zoe L.} and Kim, {Myung S.} and Lee, {David Xthona} and Rau{\'e}, {Hans Peter} and Vikram Raghunathan and Janet Griffin and Debbie Ryan and Brunton, {Amanda E.} and Curlin, {Marcel E.} and Slifka, {Mark K.} and Messer, {William B.} and Spurgeon, {Stephen E.}",

note = "Funding Information: The authors thank the subjects for participating in this research study. This work was supported in part by National Institutes of Health National Institute of Allergy and Infectious Diseases grant 1R01AI145835 (W.B.M.), by National Institutes of Health grant P51 OD011092 (M.K.S.), and endowed funds from the Knight Cancer Institute's Scholar Award for Leukemia and Lymphoma Research (S.E.S.). Funding Information: This work was supported in part by National Institutes of Health National Institute of Allergy and Infectious Diseases grant 1R01AI145835 (W.B.M.), by National Institutes of Health grant P51 OD011092 (M.K.S.), and endowed funds from the Knight Cancer Institute's Scholar Award for Leukemia and Lymphoma Research (S.E.S.).",

year = "2022",

month = feb,

day = "22",

doi = "10.1182/bloodadvances.2021006633",

language = "English (US)",

volume = "6",

pages = "1207--1211",

journal = "Blood advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "4",

}

TY - JOUR

T1 - Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia

AU - Lyski, Zoe L.

AU - Kim, Myung S.

AU - Lee, David Xthona

AU - Raué, Hans Peter

AU - Raghunathan, Vikram

AU - Griffin, Janet

AU - Ryan, Debbie

AU - Brunton, Amanda E.

AU - Curlin, Marcel E.

AU - Slifka, Mark K.

AU - Messer, William B.

AU - Spurgeon, Stephen E.

N1 - Funding Information: The authors thank the subjects for participating in this research study. This work was supported in part by National Institutes of Health National Institute of Allergy and Infectious Diseases grant 1R01AI145835 (W.B.M.), by National Institutes of Health grant P51 OD011092 (M.K.S.), and endowed funds from the Knight Cancer Institute's Scholar Award for Leukemia and Lymphoma Research (S.E.S.). Funding Information: This work was supported in part by National Institutes of Health National Institute of Allergy and Infectious Diseases grant 1R01AI145835 (W.B.M.), by National Institutes of Health grant P51 OD011092 (M.K.S.), and endowed funds from the Knight Cancer Institute's Scholar Award for Leukemia and Lymphoma Research (S.E.S.).

PY - 2022/2/22

Y1 - 2022/2/22

UR - http://www.scopus.com/inward/record.url?scp=85125384874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85125384874&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2021006633

DO - 10.1182/bloodadvances.2021006633

M3 - Letter

C2 - 34872103

AN - SCOPUS:85125384874

SN - 2473-9529

VL - 6

SP - 1207

EP - 1211

JO - Blood advances

JF - Blood advances

IS - 4

ER -

Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this